Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Impact on Functional Status in Older Adults Treated With L-Carnitine
Authors not listed
Hospital de Clínicas Dr. Manuel Quintela · 2017
Abstract
This study evaluates the impact of the treatment with L-Carnitine on the function of adults over 65 years, in conjunction with regular exercise. Simple randomization will be performed, distributing patients in 3 treatment groups, with L-Carnitine or Placebo, and with physical exercise at home or supervised.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-23 MST
Cite this
APA
Anonymous. (2017). Impact on Functional Status in Older Adults Treated With L-Carnitine. <em>Hospital de Clínicas Dr. Manuel Quintela</em>. https://clinicaltrials.gov/study/NCT03180424
Vancouver
Anonymous. Impact on Functional Status in Older Adults Treated With L-Carnitine. Hospital de Clínicas Dr. Manuel Quintela. 2017.
BibTeX
@misc{anon2017Impact,
title = {Impact on Functional Status in Older Adults Treated With L-Carnitine},
author = {Anonymous},
journal = {Hospital de Clínicas Dr. Manuel Quintela},
year = {2017},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Zheng Li 2024
Open access · US-GOV
Study of the Joint Trajectory of Frailty and Cognitive Dysfunction Among Community-dwelling Older Adults
New England Journal of Medicine 2024
Preprint · OA
Frailty in Older Adults
Maastricht University Medical Center 2017
Open access · US-GOV
Impact of Galacto-oligosaccharides on Microbial Fermentation Capacity and Markers of Frailty in Healthy Adults and Elderly
Parc de Salut Mar 2019
Open access · US-GOV
The Impact of Frailty on the Postoperative Outcomes of Gastric Cancer Surgery
University Hospital, Toulouse 2022
Open access · US-GOV
Impact of Chemotherapeutic Treatments on Functional Autonomy and Quality of Life in Patients Aged 75 Years and Over Treated for Lymphoid Hematological Malignancy
Nature Communications 2021
Open access · CC-BY